Abstract
Alternative splicing evolved as a very efficient way to generate proteome diversity from a limited number of genes, while at the same time modulating posttranscriptional events of gene expression—such as stability, turnover, subcellular localization, binding properties, and general activity of both mRNAs and proteins. Since the vast majority of human genes undergo alternative splicing, it comes to no surprise that interleukin genes also show extensive alternative splicing. In fact, there is a growing body of evidence indicating that alternative splicing plays a central role in modulating the pleiotropic functions of cytokines, and aberrant expression of alternatively spliced interleukin mRNAs has been linked to disease. However, while several interleukin splice variants have been described, their function is still poorly understood. This is particularly relevant, since alternatively spliced cytokine isoforms can act both as disease biomarkers and as candidate entry points for therapeutic intervention. In this chapter we describe a protocol that uses radiolabeled semi-quantitative RT-PCR to efficiently detect, analyze, and quantify alternative splicing patterns of cytokine genes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang ET, Sandberg R, Luo S et al (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470–476
Maniatis T, Tasic B (2002) Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418:236–243
Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291–336
Stamm S, Ben-Ari S, Rafalska I et al (2005) Function of alternative splicing. Gene 344:1–20
Braunschweig U, Gueroussov S, Plocik AM et al (2013) Dynamic integration of splicing within gene regulatory pathways. Cell 152:1252–1269
Pan Q, Shai O, Lee LJ et al (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413–1415
Singh RK, Cooper TA (2012) Pre-mRNA splicing in disease and therapeutics. Trends Mol Med 18:472–482
Lopez-Bigas N, Audit B, Ouzounis C et al (2005) Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett 579:1900–1903
Lynch KW (2004) Consequences of regulated pre-mRNA splicing in the immune system. Nat Rev Immunol 4:931–940
Martinez NM, Pan Q, Cole BS et al (2012) Alternative splicing networks regulated by signaling in human T cells. RNA 18:1029–1040
Martinez NM, Lynch KW (2013) Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn. Immunol Rev 253:216–236
Sahoo A, Im SH (2010) Interleukin and interleukin receptor diversity: role of alternative splicing. Int Rev Immunol 29:77–109
Goodwin RG, Lupton S, Schmierer A et al (1989) Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci U S A 86:302–306
Welch PA, Namen AE, Goodwin RG et al (1989) Human IL-7: a novel T cell growth factor. J Immunol 143:3562–3567
Fry TJ, Mackall CL (2002) Interleukin-7: from bench to clinic. Blood 99:3892–3904
Krawczenko A, Kieda C, Dus D (2005) The biological role and potential therapeutic application of interleukin 7. Arch Immunol Ther Exp (Warsz) 53:518–525
Maeurer MJ, Walter W, Martin D et al (1997) Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. Scand J Immunol 45:182–192
Trinder P, Seitzer U, Gerdes J et al (1999) Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. Int J Oncol 14:23–31
Korte A, Moricke A, Beyermann B et al (1999) Extensive alternative splicing of interleukin-7 in malignant hematopoietic cells: implication of distinct isoforms in modulating IL-7 activity. J Interferon Cytokine Res 19:495–503
Cosenza L, Gorgun G, Urbano A et al (2002) Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines. Cell Signal 14:317–325
Hartgring SA, Bijlsma JW, Lafeber FP et al (2006) Interleukin-7 induced immunopathology in arthritis. Ann Rheum Dis 65 Suppl 3:iii69–iii74
Fry TJ, Connick E, Falloon J et al (2001) A potential role for interleukin-7 in T-cell homeostasis. Blood 97:2983–2990
Huang HW, Chiang YJ, Hung SI et al (2007) An IL-7 splicing-defect lymphopenia mouse model revealed by genome-wide mutagenesis. J Biomed Sci 14:169–181
Chung B, Dudl E, Toyama A et al (2008) Importance of interleukin-7 in the development of experimental graft-versus-host disease. Biol Blood Marrow Transplant 14:16–27
Pan D, Liu B, Jin X et al (2012) IL-7 splicing variant IL-7delta5 induces human breast cancer cell proliferation via activation of PI3K/Akt pathway. Biochem Biophys Res Commun 422:727–731
Kroemer RT, Kroncke R, Gerdes J et al (1998) Comparison of the 3D models of four different human IL-7 isoforms with human and murine IL-7. Protein Eng 11:31–40
Vudattu NK, Magalhaes I, Hoehn H et al (2009) Expression analysis and functional activity of interleukin-7 splice variants. Genes Immun 10:132–140
Rane L, Vudattu N, Bourcier K et al (2010) Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7Ralpha) in peripheral blood from patients with multiple sclerosis (MS). J Neuroimmunol 222:82–86
Lundmark F, Duvefelt K, Iacobaeus E et al (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39:1108–1113
Moors M, Vudattu NK, Abel J et al (2010) Interleukin-7 (IL-7) and IL-7 splice variants affect differentiation of human neural progenitor cells. Genes Immun 11:11–20
Paonessa G, Graziani R, De Serio A et al (1995) Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J 14:1942–1951
Bihl MP, Heinimann K, Rudiger JJ et al (2002) Identification of a novel IL-6 isoform binding to the endogenous IL-6 receptor. Am J Respir Cell Mol Biol 27:48–56
Rincon M, Anguita J, Nakamura T et al (1997) Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 185:461–469
Zhang XY, Zhang HJ, Zhang Y et al (2006) Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics 57:934–943
Guo R, Li Y, Ning J et al (2013) HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells. PLoS One 8:e62729
Ruggiu M, Herbst R, Kim N et al (2009) Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc Natl Acad Sci U S A 106:3513–3518
Wong ML, Medrano JF (2005) Real-time PCR for mRNA quantitation. Biotechniques 39:75–85
Gibson UE, Heid CA, Williams PM (1996) A novel method for real time quantitative RT-PCR. Genome Res 6:995–1001
Horner RM (2006) Relative RT-PCR: determining the linear range of amplification and optimizing the primers:competimers ratio. CSH Protoc 2006
Bastien P, Procop GW, Reischl U (2008) Quantitative real-time PCR is not more sensitive than “conventional” PCR. J Clin Microbiol 46:1897–1900
Rio DC, Ares MJ, Hannon GJ et al (2010) Polyacrylamide gel electrophoresis of RNA. Cold Spring Harb Protoc 2010:pdb.prot5444
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Shakola, F., Byrne, S., Javed, K., Ruggiu, M. (2014). Radiolabeled Semi-quantitative RT-PCR Assay for the Analysis of Alternative Splicing of Interleukin Genes. In: Vancurova, I. (eds) Cytokine Bioassays. Methods in Molecular Biology, vol 1172. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0928-5_31
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0928-5_31
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0927-8
Online ISBN: 978-1-4939-0928-5
eBook Packages: Springer Protocols